Land: Schweiz
Språk: italienska
Källa: Swissmedic (Swiss Agency for Therapeutic Products)
haemagglutininum influenzae di tipo A (H1N1), neuraminidasum inactivatum (Virus-Stamm A/CAlifornia/7/2009 X-179A)
Emergent BioSolutions Berna GmbH
J07BB02
haemagglutininum influenzae A (H1N1), neuraminidasum inactivatum (Virus-Stamm A/CAlifornia/7/2009 X-179A)
Siringhe preriempite
haemagglutininum influenzae di tipo A (H1N1) e neuraminidasum inactivatum (Virus-Stamm A/CAlifornia/7/2009 X-179A) a 3,75 µg, adjuvans MF59: squalenum, polysorbatum 80, sorbitani trioleas, natrii citras dihydricus, acido citricum monohydricum, excipiens: natrii chloridum, kalii chloridum, kalii dihydrogenophosphas, dinatrii phosphas dihydricus, magnesio chloridum hexahydricum, calcio chloridum dihydricum, acqua q.s. la sospensione per 0,25 ml.
B
Vaccini
Vaccino Influenzale Pandemico
2009-11-13